Pronounced Therapeutic Benefit of a Single Bidirectional AAV Vector Administered Systemically in Sandhoff Mice

This publication has 50 references indexed in Scilit:

• Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
  New England Journal of Medicine, 2011
• Natural History of Infantile GM2 Gangliosidosis
  Pediatrics, 2011
• Systemic Gene Delivery in Large Species for Targeting Spinal Cord, Brain, and Peripheral Tissues for Pediatric Disorders
  Molecular Therapy, 2011
• RETRACTED ARTICLE: Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
  Nature Biotechnology, 2010
• Delivering multiple gene products in the brain from a single adeno-associated virus vector
  Gene Therapy, 2009
• Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
  Molecular Therapy, 2009
• Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
  Nature Biotechnology, 2008
• Effective gene therapy in an authentic model of Tay-Sachs-related diseases
  Proceedings of the National Academy of Sciences, 2006
• Ribosomal shunting mediated by a translational enhancer element that base pairs to 18S rRNA
  Proceedings of the National Academy of Sciences, 2006
• Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons
  Gene Therapy, 2001